A double-blind, randomized, placebo-controlled, phase III trial to investigate the efficacy and safety of glycopyrrolate in paediatric patients with chronic, moderate-to-severe drooling

Trial Profile

A double-blind, randomized, placebo-controlled, phase III trial to investigate the efficacy and safety of glycopyrrolate in paediatric patients with chronic, moderate-to-severe drooling

Completed
Phase of Trial: Phase III

Latest Information Update: 27 May 2014

At a glance

  • Drugs Glycopyrrolate (Primary)
  • Indications Sialorrhoea
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 27 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top